The Regeneration Station

The author of CELLWISE, one of the newer bio-Blogs out there, asked a question related to the Patent Reform Act of 2007 in a comment on the Pfizer post. He asked:

The article that is cited is right; our patent system is not optimized for today’s innovations or our different industries. The patent office is [...]

Filed under: Big Pharma, Innovation, Intellectual Property, Regenerative Medicine | Tagged: convergent technologies, Innovation, Patent Reform Act, patent thicket, Regenerative Medicine | No Comments »

Pfizer Global Research and Development (PGRD) has been going through some major restructuring, and in an effort to spur innovation has opened an independent research center in the Bay Area. This “biotherapeutics and bioinnovation center” will be headed up by experienced bioentrepreneur Corey Goodman. Is it possible that this could lead to some [...]

Filed under: Big Pharma, Innovation, stem cells | Tagged: Big Pharma, Innovation | 1 Comment »